Once-weekly recombinant human erythropoetin (Epoetin alfa) facilitates optimal ribavirin (RBV) dosing in hepatitis C virus (HCV)-infected patients receiving interferon-α-2b (IFN)/RBV combination therapy
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 120 (5) , A64
- https://doi.org/10.1016/s0016-5085(08)80317-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: